Skip to content

A comparative study to investigate the effect of Pulsed Ultrasound and erythromycin phonophoresis in patients with Chronic Sinusitis

A comparative study to investigate the effect of Pulsed Ultrasound and erythromycin phonophoresis in patients with Chronic Sinusitis

Status
Active, not recruiting
Phases
Unknown
Study type
Interventional
Source
IRCT
Registry ID
IRCT201203273259N2
Enrollment
30
Registered
2012-03-28
Start date
2010-07-23
Completion date
Unknown
Last updated
2018-02-22

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Condition 1: Chronic sinusitis. Condition 2: Chronic sinusitis. Chronic maxillary sinusitis Chronic frontal sinusitis

Interventions

Intervention 1: Treatment protocol for pulsed ultrasound group: Treatment duration: 5 min for each maxillary sinus, and 4 min for each frontal sinuses
Frequency: 1 MHz
Intensity: 1 W/Cm2 for maxillary sinuses and 0.5 W/Cm2 for frontal sinuses
Ultrasound type: Pulsed (ratio: 1:5). Intervention 2: Treatment protocol for phonophoresis group: Phonophoreis of erythromycin
Duration: 5 minutes for each maxillary sinuses and 4 minutes for each frontal sinuses
Frequency 1MHz
Intensity: 1 Watt/cm2 for maxllary sinus and 0.5 Watt/cm2 for frontal sinus
Ultrasound type: pulsed (1:5).
Rehabilitation
Treatment protocol for pulsed ultrasound group: Treatment duration: 5 min for each maxillary sinus, and 4 min for each frontal sinuses
Ultrasound type: Pulsed (ratio: 1:5).
Treatment protocol for phonophoresis group: Phonophoreis of erythromycin

Sponsors

Research deputy, Tehran University of Medical Sciences
Lead Sponsor

Eligibility

Sex/Gender
All
Age
18 Years to 65 Years

Inclusion criteria

Inclusion criteria: Inclusion criteria: 1) continuous symptoms for at least 3 months 2) unsuccessful medical or surgery treatments Exclusion criteria: 1)the presence of tumor in the head and face 2) contarindications for ultrasoundtherapy

Exclusion criteria

Exclusion criteria:

Design outcomes

Primary

MeasureTime frame
Percent improvement. Timepoint: pretest-posttest. Method of measurement: Change in symptom score devided by pre score multiplied by 100.

Countries

Iran (Islamic Republic of)

Contacts

Public ContactDr. Noureddin Nakhostin Ansari

School of Rehabilitation, Tehran University of Medical Sciences

nakhostin@sina.tums.ac.ir+98 21 7753 3939

Outcome results

None listed

Source: IRCT (via WHO ICTRP) · Data processed: Feb 4, 2026